SOPH

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change -0.04
Percentage change -1.12	%

Peers: ILMN QGEN GH TXG OMIC CRSP EDIT NTLA DNA PACB

| Held by: ONEQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.09	Insider Own	21.75%	Shs Outstand	66.44M	Perf Week	-17.79%
Market Cap	232.72M	Forward P/E	-	EPS next Y	-0.79	Insider Trans	0.00%	Shs Float	51.15M	Perf Month	5.95%
Income	-71.40M	PEG	-	EPS next Q	-0.20	Inst Own	27.44%	Short Float	0.06%	Perf Quarter	-0.29%
Sales	64.49M	P/S	3.61	EPS this Y	27.32%	Inst Trans	0.11%	Short Ratio	0.58	Perf Half Y	-20.36%
Book/sh	1.71	P/B	2.08	EPS next Y	11.28%	ROA	-37.24%	Short Interest	0.03M	Perf Year	-19.46%
Cash/sh	1.47	P/C	2.43	EPS next 5Y	20.99%	ROE	-52.51%	52W Range	2.70 - 7.37	Perf YTD	15.95%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-23.22%	ROI	-50.03%	52W High	-51.70%	Beta	1.04
Dividend TTM	-	Quick Ratio	3.59	Sales past 5Y	25.78%	Gross Margin	67.82%	52W Low	31.84%	ATR (14)	0.40
Dividend Ex-Date	-	Current Ratio	3.80	EPS Y/Y TTM	-1.73%	Oper. Margin	-105.89%	RSI (14)	50.54	Volatility	21.25% 11.69%
Employees	449	Debt/Eq	0.28	Sales Y/Y TTM	9.85%	Profit Margin	-110.71%	Recom	1.33	Target Price	7.00
Option/Short	Yes / Yes	LT Debt/Eq	0.26	EPS Q/Q	-30.74%	Payout	-	Rel Volume	0.43	Prev Close	3.60
Sales Surprise	-0.04%	EPS Surprise	-26.13%	Sales Q/Q	-2.76%	Earnings	Nov 05 BMO	Avg Volume	51.89K	Price	3.56
SMA20	3.27%	SMA50	6.19%	SMA200	-11.14%	Trades		Volume	15,839	Change	-1.12%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-18-24	Initiated	Craig Hallum	Buy	$11
Aug-07-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$10 → $5
Jun-27-24	Initiated	Guggenheim	Buy	$6
Nov-29-23	Initiated	RBC Capital Mkts	Outperform	$8
Jul-05-23	Resumed	JP Morgan	Overweight	$10
Jan-03-23	Initiated	BTIG Research	Buy	$6
Nov-23-22	Initiated	Credit Suisse	Neutral	$2
Oct-15-21	Resumed	Cowen	Outperform
Aug-17-21	Initiated	Morgan Stanley	Overweight	$24
Aug-17-21	Initiated	JP Morgan	Overweight	$23
Aug-17-21	Initiated	Credit Suisse	Outperform	$22
Aug-17-21	Initiated	Cowen	Outperform

Show Previous Ratings

Jan-28-25 08:59AM	SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities (PR Newswire)
Nov-21-24 05:30AM	SOPHiA GENETICS Launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024 (PR Newswire)
Nov-06-24 06:59AM	SOPHiA GENETICS Faces Financial Challenges Amid Losses (TipRanks) -9.33%
02:08AM	Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
12:10AM	Q3 2024 Sophia Genetics SA Earnings Call (Thomson Reuters StreetEvents)
06:32AM	Loading…
Nov-05-24 06:32AM	SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer (PR Newswire)
06:30AM	SOPHiA GENETICS Reports Third Quarter 2024 Results (PR Newswire)
Nov-04-24 09:57AM	SOPHiA GENETICS SA (SOPH): A Bull Case Theory (Insider Monkey)
07:13AM	Sophia Genetics SA (SOPH) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-22-24 06:45AM	SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024 (PR Newswire)
Sep-14-24 09:00AM	SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024 (PR Newswire)
Sep-12-24 07:00AM	SOPHiA GENETICS Announces Poster Presentations at ESMO 2024 (PR Newswire)
04:00AM	SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024 (PR Newswire)
Sep-11-24 07:33AM	Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout (Medical Device Network) +8.70%
Sep-10-24 10:28AM	SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing (PR Newswire)
08:30AM	Loading…
Sep-05-24 08:30AM	SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024 (PR Newswire) +5.59%
Sep-04-24 06:00AM	SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024 (PR Newswire)
Aug-28-24 01:30PM	SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference (PR Newswire) +5.26%
Aug-14-24 09:13AM	Sophia Genetics secures CE mark for DDM analytics platform under EUs IVDR (Medical Device Network)
03:00AM	SOPHiA DDM Platform Certified Under IVDR (PR Newswire)
Aug-12-24 09:35AM	SOPHiA GENETICS (SOPH) Loses -30.47% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Aug-09-24 12:00PM	What Makes SOPHiA GENETICS (SOPH) a New Buy Stock (Zacks)
Aug-06-24 07:55AM	SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
06:45AM	SOPHiA GENETICS Reports Second Quarter 2024 Results (PR Newswire)
Jul-29-24 10:30AM	SOPHiA GENETICS Announces L'hpital Universitaire Avicenne is Live on SOPHiA DDM (PR Newswire)
Jul-24-24 11:59AM	SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix (PR Newswire)
Jul-23-24 06:45AM	SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024 (PR Newswire)
Jul-05-24 04:32AM	Indias Dhiti Omics deploys SOPHiA DDM platform for solid tumour testing (Medical Device Network)
Jul-04-24 02:30AM	India-Based Dhiti Omics is Now Live on SOPHiA DDM (PR Newswire)
Jun-24-24 09:47AM	SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting (GlobeNewswire)
02:00AM	Loading…
02:00AM	SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application (PR Newswire)
Jun-13-24 06:00AM	SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM Platform (PR Newswire)
May-30-24 12:39PM	SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care (PR Newswire)
May-29-24 10:00AM	SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities (PR Newswire)
May-20-24 10:02AM	SOPHiA GENETICS Announces Instituto Mrio Penna as New Customer (PR Newswire)
May-16-24 06:02AM	Klinikum Klagenfurt am Wrthersee is Live with SOPHiA GENETICS (PR Newswire)
May-13-24 12:22PM	SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-07-24 10:53AM	SOPH Stock Earnings: Sophia Genetics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:55AM	Wall Street Analysts Think SOPHiA GENETICS (SOPH) Could Surge 64.95%: Read This Before Placing a Bet (Zacks)
06:45AM	SOPHiA GENETICS Reports First Quarter 2024 Results (GlobeNewswire)
Apr-30-24 07:05AM	SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
Apr-23-24 10:29AM	SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024 (GlobeNewswire)
06:37AM	Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering (MT Newswires)
05:05AM	SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa (PR Newswire)
Apr-17-24 06:05AM	SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD) (PR Newswire)
Apr-04-24 01:00AM	SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership (PR Newswire)
Apr-02-24 10:00AM	Laboratorio Barnafi-Krause is Live on SOPHiA DDM (PR Newswire)
Mar-20-24 10:00AM	SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada (PR Newswire) +5.78%
Mar-15-24 06:00AM	SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration (PR Newswire) +5.94%
Mar-07-24 12:07PM	SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference (GlobeNewswire)
Mar-06-24 08:31AM	SOPHiA GENETICS SA (NASDAQ:SOPH) Q4 2023 Earnings Call Transcript (Insider Monkey) -10.54%
03:15AM	Q4 2023 Sophia Genetics SA Earnings Call (Thomson Reuters StreetEvents)
Mar-05-24 06:45AM	SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Feb-22-24 08:45AM	SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference (GlobeNewswire)
Feb-20-24 10:46AM	SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024 (GlobeNewswire) +10.68%
Feb-07-24 06:51AM	SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain (PR Newswire)
Jan-25-24 10:50AM	SOPHiA GENETICS Supports Genetic Testing in Brazil (PR Newswire)
Jan-18-24 03:00PM	SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio (PR Newswire)
Jan-14-24 11:00PM	SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India (PR Newswire)
Jan-10-24 05:15PM	SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-08-24 09:08AM	Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data Analytics (PR Newswire)
Dec-21-23 07:00AM	Hpital Saint-Louis Implements SOPHiA DDM Platform to Further Research of Myeloid Disorders (PR Newswire)
Dec-14-23 12:43PM	SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference (GlobeNewswire)
Dec-07-23 09:01AM	SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy Offerings (PR Newswire)
Nov-30-23 07:01AM	SOPHiA GENETICS Announces Expansion of Work with CHU de Nmes (PR Newswire)
Nov-28-23 07:00AM	SOPHiA GENETICS Expands Relationship with Citt della Salute e della Scienza di Torino (PR Newswire)
Nov-17-23 07:23AM	The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICS (PR Newswire)
Nov-12-23 08:32AM	SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 06:45AM	BioReference Signs On as the First Laboratory to Use MSK-ACCESS Powered with SOPHiA DDM (PR Newswire)
06:30AM	SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023 (GlobeNewswire)
Oct-24-23 05:50AM	SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023 (GlobeNewswire) +11.51%
Oct-18-23 08:00AM	SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care (PR Newswire)
Sep-29-23 06:03AM	Shaare Zedek Medical Center Uses SOPHiA GENETICS to Advance Research of Myeloid Disorders (PR Newswire)
Sep-13-23 10:05AM	Laboratorio Curie Expands Relationship with SOPHiA GENETICS (PR Newswire) -7.94%
Sep-07-23 06:22AM	SOPHiA GENETICS Announces the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) is Live on the SOPHiA DDM Platform (PR Newswire) +9.44%
Aug-30-23 06:05AM	CHU Bordeaux is live on SOPHiA GENETICS (PR Newswire)
Aug-22-23 06:05AM	SOPHiA GENETICS Expands Relationship with Gustave Roussy (PR Newswire)
Aug-17-23 07:34AM	A.O.U. San Giovanni di Dio Ruggi d'Aragona Expands Usage of SOPHiA GENETICS DDM Platform (PR Newswire) -11.54%
Aug-08-23 08:25AM	SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +5.65%
07:10AM	SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2023 (GlobeNewswire)
06:55AM	Tulane University School of Medicine Uses SOPHiA GENETICS to Advance Research of Blood Cancers (PR Newswire)
Jul-25-23 07:35AM	SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2023 on August 8, 2023 (PR Newswire)
Jul-13-23 06:09AM	SOPHiA GENETICS Announces Gruppo Centro Servizi Medici (CSM) is Live on the SOPHiA DDM Platform (PR Newswire)
Jul-07-23 06:04AM	Centre Hospitalier de Bastia is Live on SOPHiA GENETICS (PR Newswire)
Jul-02-23 10:33AM	SOPHiA GENETICS (NASDAQ:SOPH) swells 17% this week, taking one-year gains to 20% (Simply Wall St.)
Jun-26-23 11:03AM	SOPHiA GENETICS Publishes Results of 2023 Annual General Meeting (PR Newswire)
Jun-22-23 06:00AM	Ankara Etlik City Hospital is Live on SOPHiA GENETICS Platform (PR Newswire)
Jun-15-23 10:13AM	NOMAD Genetics is Live on the SOPHiA GENETICS Platform (PR Newswire) -6.14%
Jun-05-23 09:10AM	Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth? (Simply Wall St.) -5.64%
Jun-02-23 09:31AM	SOPHiA GENETICS Joins CancerX to Help Accelerate Cancer Research (PR Newswire)
May-31-23 09:12AM	SOPHiA GENETICS Announces Nomination of Lila Tretikov to Board of Directors (PR Newswire)
May-24-23 06:00AM	Institute of Oncology Ljubljana Leverages SOPHiA DDM Platform for Cancer Research (PR Newswire)
May-16-23 09:09AM	Natural State Laboratories Chooses SOPHiA GENETICS to Help Launch their In-House Hereditary Cancer Testing (PR Newswire) -5.16%
May-15-23 10:26AM	Dasa Expands Its Capabilities with SOPHiA GENETICS (PR Newswire)
May-09-23 08:05AM	SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:55AM	SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2023 (GlobeNewswire)
May-03-23 06:00AM	SOPHiA GENETICS SOPHiA DDM HRD Solution is Tapped by Unipath Specialty Laboratory Limited (Business Wire)
Apr-25-23 09:00AM	SOPHiA GENETICS Celebrates Swiss Biotech Award (Business Wire)
07:11AM	SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2023 on May 9, 2023 (GlobeNewswire)
Apr-18-23 09:00AM	The University of Maryland Medical Center Chooses SOPHiA GENETICS Technology (Business Wire) +11.35%

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
PHILIPPE MENU	Officer	Jan 27 '25	Proposed Sale	4.20	7,500	31,500	Jan 27 04:26 PM
JURGI CAMBLONG	Director	Jan 27 '25	Proposed Sale	4.20	28,500	119,700	Jan 27 04:25 PM
JURGI CAMBLONG	Director	Jan 24 '25	Proposed Sale	4.33	18,758	81,222	Jan 24 04:18 PM
MANUELA VALENTE	Officer	Dec 24 '24	Proposed Sale	3.31	3,423	11,330	Dec 26 08:14 AM
JURGI CAMBLONG	Director	Dec 24 '24	Proposed Sale	3.31	40,343	133,535	Dec 26 08:14 AM
ZHENYU XU	Officer	Dec 24 '24	Proposed Sale	3.31	6,152	20,363	Dec 26 08:14 AM
DAAN GUIDO MARIA VAN WELL	Officer	Dec 24 '24	Proposed Sale	3.31	5,815	19,248	Dec 26 08:14 AM
ROSS J MUKEN	Officer	Dec 19 '24	Proposed Sale	3.40	6,762	22,991	Dec 19 04:19 PM
PHILIPPE MENU	Officer	Dec 19 '24	Proposed Sale	3.40	5,544	18,850	Dec 19 04:19 PM
ZHENYU XU	Officer	Dec 13 '24	Proposed Sale	3.29	4,000	13,140	Dec 13 04:27 PM
Zhenyu Xu	Officer	Nov 19 '24	Proposed Sale	3.30	792	2,614	Nov 19 02:52 PM
Ross Muken	Officer	Nov 19 '24	Proposed Sale	3.30	1,485	4,900	Nov 19 02:50 PM
Philippe Menu	Officer	Nov 19 '24	Proposed Sale	3.30	792	2,614	Nov 19 02:49 PM
Manuela Valente	Officer	Nov 19 '24	Proposed Sale	3.30	495	1,634	Nov 19 02:48 PM
Jurgi Camblong	Director	Nov 19 '24	Proposed Sale	3.30	5,839	19,269	Nov 19 02:46 PM
Daan Guido Maria Van Well	Officer	Nov 19 '24	Proposed Sale	3.30	890	2,937	Nov 19 02:45 PM
Zhenyu Xu	Officer	Oct 22 '24	Proposed Sale	3.30	792	2,614	Oct 22 09:17 PM
Ross Muken	Officer	Oct 22 '24	Proposed Sale	3.30	1,484	4,897	Oct 22 09:17 PM
Philippe Menu	Officer	Oct 22 '24	Proposed Sale	3.30	792	2,614	Oct 22 09:17 PM
Manuela Valente	Officer	Oct 22 '24	Proposed Sale	3.30	495	1,634	Oct 22 09:17 PM
Jurgi Camblong	Officer	Oct 22 '24	Proposed Sale	3.30	5,838	19,265	Oct 22 09:16 PM
Daan Guido Maria Van Well	Officer	Oct 22 '24	Proposed Sale	3.30	892	2,944	Oct 22 09:16 PM
Daan Guido Maria Van Well	Officer	Oct 04 '24	Proposed Sale	3.24	2,946	9,545	Oct 04 03:44 PM
Jurgi Camblong	Officer	Oct 04 '24	Proposed Sale	3.24	21,456	69,517	Oct 04 03:43 PM
Ross Muken	Officer	Oct 04 '24	Proposed Sale	3.24	3,236	10,485	Oct 04 03:42 PM
Philippe Menu	Officer	Oct 04 '24	Proposed Sale	3.24	3,670	11,891	Oct 04 03:41 PM
Manuela Valente	Officer	Oct 04 '24	Proposed Sale	3.24	1,860	6,026	Oct 04 03:40 PM
Zhenyu Xu	Officer	Oct 04 '24	Proposed Sale	3.24	3,670	11,891	Oct 04 03:38 PM
Zhenyu Xu	Officer	Sep 19 '24	Proposed Sale	4.23	1,602	6,776	Sep 19 09:31 PM
Ross Muken	Officer	Sep 19 '24	Proposed Sale	4.23	2,969	12,559	Sep 19 09:31 PM
Philippe Menu	Officer	Sep 19 '24	Proposed Sale	4.23	1,583	6,696	Sep 19 09:31 PM
Manuela Valente	Officer	Sep 19 '24	Proposed Sale	4.23	995	4,209	Sep 19 09:30 PM
Daan Guido Maria Van Well	Officer	Sep 19 '24	Proposed Sale	4.23	1,670	7,064	Sep 19 09:30 PM
Jurgi Camblong	Officer	Sep 19 '24	Proposed Sale	4.23	11,719	49,571	Sep 19 09:30 PM
ZHENYU XU	Officer	Sep 13 '24	Proposed Sale	3.90	12,000	46,800	Sep 13 04:21 PM
KATHY L HIBBS	Officer	Sep 09 '24	Proposed Sale	3.75	16,080	60,300	Sep 09 04:28 PM
Philippe Menu	Officer	Aug 19 '24	Proposed Sale	3.34	792	2,645	Aug 19 09:07 PM
La Piece 12 CH-1180	Officer	Aug 19 '24	Proposed Sale	3.34	478	1,597	Aug 19 09:07 PM
Jurgi Camblong	Officer	Aug 19 '24	Proposed Sale	3.34	5,609	18,734	Aug 19 09:06 PM
Daan Van Well	Officer	Aug 19 '24	Proposed Sale	3.34	861	2,876	Aug 19 09:06 PM
Zhenyu Xu	Officer	Aug 19 '24	Proposed Sale	3.34	792	2,645	Aug 19 09:06 PM
Ross Muken	Officer	Aug 19 '24	Proposed Sale	3.34	810	2,705	Aug 19 09:06 PM
KATHY L HIBBS	Officer	Aug 09 '24	Proposed Sale	3.36	15,777	52,932	Aug 09 04:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SOPHiA Genetics SA

Upgrade your FINVIZ experience